What is refractory diffuse large B cell lymphoma?
Refractory DLBCL (including subtypes PMBCL and TFL) was defined as progressive disease (received ≥4 cycles of first-line therapy) or stable disease (received 2 cycles of later-line therapy) as best response to chemotherapy or relapse ≤12 months after ASCT.Besides, how do you treat relapsed/refractor...